Cognitive Deficit
29
6
8
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.9%
2 terminated out of 29 trials
80.0%
-6.5% vs benchmark
3%
1 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (29)
Prevalence of Mild Cognitive Impairment and Dementia in Patients Admitted to Non-neurological Rehabilitation Wards
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
Patient-Centered NeuroRehabilitation (PCN)
Factors Predicting Outcome in Group Treatment of Alcohol Use Disorders (AUDs)
Studying the Effects of Brain Stimulation on Cognitive Control and Associated EEG in Human Subjects.
Cognitive Rehabilitation in People With Metabolic Syndrome and Mild Cognitive Deficits
Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits
Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation
Neurorehabilitation Through Hippotherapy of a Brain Stroke
Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS
Investigating the Use of Goal Management Therapy in Improving Cognitive Functioning in Public Safety Personnel With PTSD
Validation of a Digital Self-Administered Cognitive Screening Tool: MoCA-XpressO
Goal Management Training in Individuals With PTSD
Effects of PEA-LUT on Frontal Lobe Functions and GABAergic Transmission in Long-Covid Patients
Validation Study SCOBES-AR
Swiss SOS MoCA - DCI Study
Neurofeedback Effectiveness Trial in PTSD
Cognitive Intervention in Attention Deficit and Hyperactivity Disorder
Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients